Cargando…
Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5–17-year-old children in the United States
Vaccine development against COVID-19 has mitigated severe disease. However, reports of rare but serious adverse events following immunization (sAEFI) in the young populations are fuelling parental anxiety and vaccine hesitancy. With a very early season of viral illnesses including COVID-19, respirat...
Autores principales: | Mangat, Halinder S., Rippon, Brady, Reddy, Nikita T., Syed, Akheel A., Maruthanal, Joel M., Luedtke, Susanne, Puthumana, Jyothy J., Srivatsa, Abhinash, Bosman, Arnold, Kostkova, Patty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937486/ https://www.ncbi.nlm.nih.gov/pubmed/36800368 http://dx.doi.org/10.1371/journal.pone.0281993 |
Ejemplares similares
-
Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on
por: Mangat, Halinder S., et al.
Publicado: (2022) -
Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury
por: Mangat, Halinder S.
Publicado: (2018) -
Editorial: Digital interventions and serious mobile games for health in low- and middle-income countries (LMICs)
por: Borda, Ann, et al.
Publicado: (2023) -
Towards Improved Organizational Governance of Neurotrauma Surveillance: Comment on "Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries"
por: Schenck, Hanna E., et al.
Publicado: (2023) -
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)